Correlation between thyroid autoantibodies and cardiovascular disease in patients with stages 3-5 chronic kidney

Weicheng Xu1,2, Shiyi Liang1, Yuxiang Huang3

  • 1Department of Nephrology, Institute of Nephrology and Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.

Insights

Thyroid autoantibodies are linked to cardiovascular disease risks in chronic kidney disease (CKD) patients, particularly affecting triglycerides, anemia, and inflammation. Female CKD patients with high thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TGAb) titers require attention.

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiology

Background:

  • Chronic kidney disease (CKD) is frequently comorbid with thyroid and cardiovascular diseases (CVD).
  • The association between thyroid autoantibodies and cardiac/renal function in CKD patients remains underexplored.

Purpose of the Study:

  • To investigate the relationship between thyroid autoantibodies and cardiac/renal function in patients with stages 3-5 CKD.

Main Methods:

  • A cross-sectional study involving 1,164 CKD patients (stages 3-5).
  • Collected clinical data, laboratory indexes, and echocardiographic parameters (e.g., E/E' ratio, LVEF).

Main Results:

  • Thyrotropin receptor antibody (TRAb) correlated positively with C-reactive protein.
  • Thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TGAb) titers were higher in male diabetic patients and negatively correlated with hemoglobin in female patients.
  • TPOAb positivity was associated with higher E/E' ratio and LVEF, while TRAb negatively correlated with LVEF.

Conclusions:

  • Autoimmune thyroid disease (AITD) may elevate CVD risk in CKD patients via triglyceride levels, anemia, and micro-inflammation.
  • Female patients with elevated TPOAb and TGAb warrant close monitoring.
  • TPOAb-positive women may have an increased risk of diastolic heart failure.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
165
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
136
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
202
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
239
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
91
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
88